SimonAlexanderRitchieMD
Dermatology • Claymont, DEAssistant Professor, Dermatology, Uniformed Services Hebert SOM
Dr. Ritchie is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2093 Philadelphia Pike #2696
Claymont, DE 19703Fax+1 218-228-0904
Education & Training
University of LouisvilleCertificate, Biostatistics, 2021 - 2023
University of MarylandResidency, Dermatology, 2010 - 2013
David Grant Medical CenterInternship, Transitional Year, 2007 - 2008
Uniformed Services University of the Health Sciences F. Edward Hebert School of MedicineClass of 2007
Certifications & Licensure
FL State Medical License 2022 - Present
CA State Medical License 2022 - 2026
WA State Medical License 2023 - 2026
VT State Medical License 2022 - 2026
TN State Medical License 2024 - 2026
ND State Medical License 2022 - 2026
NY State Medical License 2022 - 2026- American Board of Dermatology Dermatology
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsShaving Waivers in the United States Air Force and Their Impact on Promotions of Black/African-American MembersSimon Ritchie, Jisuk Park, Jonathan Banta, Casey Bowen, Sean McCarthy
Military Medicine. 2021-07-06 - 8 citationsPredictive value of basal cell carcinoma biopsies with negative margins: A retrospective cohort studyHal Bret Willardson, Jamie Lombardo, Matt Raines, Tina Nguyen, Jisuk Park
Journal of the American Academy of Dermatology. 2018-07-01 - 14 citationsA phase 2a, open-label pilot study of the galectin-3 inhibitor GR-MD-02 for the treatment of moderate-to-severe plaque psoriasisSimon Ritchie, Danielle Neal, Harold Shlevin, Adam Allgood, Peter G. Traber
Journal of the American Academy of Dermatology. 2017-10-01
Press Mentions
GR-MD-02 Demonstrates Clinically Significant Effect in Patients with Severe and Refractory Atopic Dermatitis (Eczema)March 14th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
